van Lingen, Rosanne G <br/><br/>
Persistent expression of CD26/DPPIV after treatment with infliximab in psoriasis despite clinical improvement.  [electronic resource] 

 -  Acta dermato-venereologica  2009 
 - 518-20 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Letter 
<br/><br/><label>ISSN: </label>1651-2057 
<br/><br/><label>Standard No.: </label>10.2340/00015555-0675  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies, Monoclonal--therapeutic use<br/>Biopsy<br/>Dermatologic Agents--therapeutic use<br/>Dipeptidyl Peptidase 4--metabolism<br/>Female<br/>Humans<br/>Infliximab<br/>Keratinocytes--drug effects<br/>Male<br/>Middle Aged<br/>Psoriasis--drug therapy<br/>Severity of Illness Index<br/>T-Lymphocytes--drug effects<br/>Time Factors<br/>Treatment Outcome